Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Recursion Pharmaceuticals Inc., 3 years.
Recursion Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +3,747 | — | — |
| Jun 17, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +88,424 | — | — |
| Apr 29, 2026 | Merck & Company Inc. | Option exercise | +4,722 | $110.03 | $519,562 |
| Apr 29, 2026 | Merck & Company Inc. | Shares withheld for tax | −2,326 | $110.03 | $255,930 |
| Apr 1, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +3,268 | — | — |
| Feb 10, 2026 | Merck & Company Inc. | Open-market sale | −10,235 | $117.52 | $1,202,817 |
| Feb 4, 2026 | Merck & Company Inc. | Option exercise | +15,087 | $56.04 | $845,475 |
| Feb 4, 2026 | Merck & Company Inc. | Open-market sale | −15,087 | $118.77 | $1,791,883 |
| Jan 26, 2026 | Merck & Company Inc. | Grant or award | +20,469 | $107.40 | $2,198,371 |
| Jan 2, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +2,381 | — | — |
| Oct 1, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +1,961 | — | — |
| Jul 1, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +1,949 | — | — |
| Jun 18, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +22,016 | — | — |
| Apr 1, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +2,268 | — | — |
| Jan 27, 2025 | Merck & Company Inc. | Grant or award | +32,621 | $97.94 | $3,194,901 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.